Abstract-A tumor-targeting antisense oligodeoxynucleotide (ODN) delivery system based on polyelectrolyte complex (PEC) micelles is demonstrated. ODN-PEG-folic acid (ODN-PEG-FA) was synthesized using a heterofunctional PEG linker. The PEC micelles for the targeted ODN delivery to tumor cells were produced by ionic interactions between the ODN-PEG-FA and polyethylenimine (PEI). The in vivo targeting properties of the PEC micelles were assessed using a mouse tumor model. The size of ODN-PEG-FA/PEI PEC micelles was 92.3 nm with a relatively narrow distribution. Cellular uptake of the ODN-PEG-FA/PEI PEC micelles by folic acid receptor over-expressing cells (KB) was greatly enhanced compared to that of ODN-PEG/PEI PEC micelles. When the ODN-PEG-FA/PEI PEC micelles were systemically administered to the mice bearing KB cell xenograft tumor, ODN was accumulated to the solid tumor in a target specific manner. This study suggests that the PEC micelles with a receptor-recognizable targeting ligand on the surface have potential for passive and active targeted delivery of ODN drugs to cancer cells.
INTRODUCTION
Non-viral polymeric delivery systems having a tumor specific targeting capability have been recognized as an attractive gene therapy approach for systemic cancer treatment [1 -3] . A variety of cationic polymers has been used to form a nanosized complex structure with either a plasmid DNA encoding a therapeutic gene or an anti-sense oligodeoxynucleotide (ODN). The polyelectrolyte complex (PEC) nanoparticles, formed from the interaction between a positively charged polymer and a negatively charged DNA, have an average diameter of less than 200 nm. The PEC nanoparticles are generally positively charged and taken up by cells via adsorptive endocytosis. To improve cellular uptake efficacy at a tumor site and to minimize the potential side effect at other tissues, tumor cell-specific targeting ligands were conjugated to the cationic polymers [4 -6] . However, the problems associated with rapid clearance and undesirable pharmacokinetic profiles of the PEC nanoparticles in vivo have yet been solved [7, 8] .
Recently, self-assembling di-block copolymer micelles have received much attention as potential vehicles for anti-cancer drugs, including anti-sense ODNs [9 -12] . The micelles are generally composed of a hydrophobic core and a surrounding hydrophilic shell. The surrounding hydrophilic shell in conjunction with their small size (generally less than 100 nm) could protect the micelles from non-specific adsorption of opsonins and other serum proteins in the blood stream. These advantages give the micellar carriers a chance to avoid the reticulo-endothelial system, which leads to prolonged circulation of the micelles when systematically injected [13, 14] . The nano-sized polymeric micelles are also expected to show enhanced penetration into loosened vascular endothelial cell junctions of fast-growing tumor tissues [15] . Previously, we conjugated poly(ethylene glycol) (PEG) to ODN to prepare an ODN-PEG conjugate. The DNA/PEG conjugate can interact with various polycations, such as cationic fusogenic peptide (KALA), PEI, poly(L-lysine) and protamine, to produce polyelectrolyte complex (PEC) micelles [16] . The negatively charged ODN part of the conjugate interacts with the cationic peptides or polymers to form a charge-neutralized inner core, while the PEG part surrounds it as a protective shell. The PEC micelles demonstrated the enhanced cellular uptake of antisense ODN and the improved retardation in tumor growth in vitro as well as in vivo [17] . Our previous studies also suggested that the ODN-PEG conjugate had a similar biological activity to that of naked ODN within the intracellular compartment.
Folic acid receptor has been identified as a potential target molecule of various cancer cells. The receptor is up-regulated and over-expressed in a number of rapidly-growing malignant tumor cells, which results in a dramatic promotion of the cellular uptake of folate [18] . Therefore, the conjugation of folic acid to a variety of polymeric and lipid carriers has been chosen as a popular strategy for the targetspecific delivery of anti-cancer therapeutics to the receptor-bearing tumor cells. Attachment of folic acid to lipid [19] , cationic polymers [4, 6] and anti-sense ODN [20] has been shown to be an efficient way for the tumor-targeted gene delivery. To this end, the introduction of a targeting moiety, folic acid, to the PEC micelles could promote not only their intracellular transport efficiency, but also specificity toward tumor cells. In this study, folic acid (FA) was conjugated to ODN via a PEG linker (ODN-PEG-FA) to prepare the PEC micelles with PEI for the targeted delivery of antisense ODN to tumor cells. In vitro cellular uptake, in vivo tumor accumulation and in vivo tumor targeting of the PEC micelles were investigated. 3 ) were purchased from Aldrich (Milwaukee, WI, USA). Cell culture materials, RPMI 1640 medium and fetal bovine serum (FBS) were purchased from Invitrogen (Carlsbad, CA, USA). All other chemicals were of analytical grade and used without further purification.
MATERIALS AND METHODS

Materials
Synthesis of ODN-PEG-FA conjugate
The scheme of the synthesis of the ODN-PEG-FA conjugate is shown in Fig. 1 . 130 mg (0.30 mmol) of FA dissolved in anhydrous DMSO was activated by adding dicyclohexyl carbodiimide (60.6 mg, 0.30 mmol) and N -hydroxyl succinimide (33.8 mg, 0.30 mmol) under nitrogen at room temperature for 30 min. Cystamine (33.8 mg, 0.15 mmol) dissolved in DMSO was then added and the reaction was carried out for 3 h in the presence of pyridine. The stoichiometric molar ratio of FA/cytamine/pyridine was 2 : 1 : 25. The resulting product was filtered through a 0.2 µm filter (Millipore, Bedford, MA, USA), dialyzed against deionized water and lyophilized under reduced pressure. The cystamine-(FA) 2 was dissolved in DMSO/H 2 O (50 : 50) and reduced to produce a free thiol group ( SH) in the presence of 0.1 M 2-mercaptoethanol. The FA-SH was dialyzed against vacuumdegassed deionized H 2 O containing 10 mM EDTA with continuous nitrogen purging through the solution. The resulting FA-SH was freeze-dried. To synthesize ODN-PEG-FA, ODN with a 5 -terminal primary amine (1 mg, 180 nmol) was added to a hetero-functional PEG (NHS-PEG-MAL, 1 mg, 540 nmol), in sodium phosphate buffer (10 mM NaH 2 PO 4 /Na 2 HPO 4 , 100 mM NaCl, 2 mM EDTA, pH 7.2). After 1.5 h incubation at room temperature, the FA-SH (0.1 mg, 1.8 µmol) dissolved in DMSO was added to the ODN-PEG-MAL in an aqueous solution (50 : 50, v/v) at room temperature for 3 h. The product was dialyzed against deionized H 2 O (MWCO 5000). Insoluble products were removed by filtration. The synthesis of ODN-PEG-FA was monitored by using reverse-phase chromatography (C 18 column, 200 × 4.6 mm, Waters, Milford, MA, USA) with detection at 260 nm using a gradient from 5 to 50% acetonitrile in 0.1 M triethylammonium acetate with a flow rate of 1.0 ml/min at 56
• C. It was confirmed that unconjugated low-molecularweight species were completely removed by dialysis. 
Preparation of polyelectrolyte complex micelles
The ODN-PEG-FA and PEI solutions were separately filtered through a 0.2 µm filter unit (Millipore). The solutions were mixed at a nitrogen/phosphate (N/P) ratio of 2.5 : 1 and incubated at room temperature for 30 min to form PEC micelles. Effective hydrodynamic diameter of the PEC micelles was measured by dynamic light scattering at 25
• C using a dynamic light scattering photometer (Zeta Plus, Brookhaven Instruments, New York, NY, USA) equipped with 632-nm He-Ne laser at a 90
• detection angle.
Cell culture
A human epidermal carcinoma cell line from an oral cavity (KB cells) and a human lung carcinoma cell line (A549 cells) were purchased from the Korea Cell Line Bank (Seoul, South Korea). The cells were maintained in RPMI 1640 medium, supplemented with 100 units/ml penicillin, 100 µg/ml streptomycin and 10% FBS. The cells were cultured as a monolayer in a humidified atmosphere containing 5% CO 2 at 37
• C. For injection into mice, the cells were grown until confluency, detached with trypsin/EDTA, washed three times with PBS and resuspended in PBS.
Flow cytometric analysis
The ODN with the modified ends (3 -FITC and 5 -amine) were used for the synthesis of ODN-PEG and ODN-PEG-FA to label the PEC micelles. Confluent cells were trypsinized and 10 5 cells per well were plated in a 6-well plate in 1.5 ml RPMI 1640 with 10% FBS and incubated for 24 h before further experiments. Culture medium was replaced by fresh serum-free medium before addition of the FITC-labeled ODN-PEG-FA/PEI PEC micelles. The amount of ODN incorporated within the micelles was adjusted to 10 µg/ml. After 3 h incubation, the medium was discarded and the cells were extensively washed with PBS. The cells were fixed in 1% paraformaldehyde in PBS and stored at 4
• C for 30 min. The fixed cells were washed three times with PBS and stored in 0.1% paraformaldehyde before measurement. The cellular uptake efficiency was determined by using flow cytometry (FACS Caliber, Becton-Dickinson, Mountain View, CA, USA). At least 10 4 events were analyzed to generate each histogram.
Bio-distribution study
An animal tumor model was generated by a subcutaneous injection of 10 6 cells (either KB or A549 cells) into rear flanks of 8-weeks-old female nude mice (nu/nu, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea). The FITC-labeled ODN-PEG-FA/PEI PEC micelles (100 µg of ODN equivalent) were administered to the tumor-bearing nude mice via a tail vein. A group of mice was killed at 3 h and 24 h after the injection. Major organs (liver, lung, spleen, kidney and heart), blood and tumor cells were harvested. Blood samples were collected in EDTA-coated tubes. Other tissues were washed with PBS to remove blood and weighed. The tissues from the various organs and tumor were ground in a hypotonic solution by using a tissue homogenizer. The homogenized tissue solutions were centrifuged and filtered through a 0.45 µm filter membrane (Millipore). In vivo tissue distribution and deposition of ODN was measured by monitoring the fluorescent intensity from the tissue extract at 494 nm (excitation) and 520 nm (emission) using a spectrofluorometer (SLM-AMINCO 8100, SLM Instruments, Urbana, IL, USA) and expressed as percent initial dosage per gram tissue.
RESULTS AND DISCUSSION
The ODN delivery system based on PEC micelles has been thought to be an attractive candidate for anti-sense ODN therapy for cancer treatment. The PEC micelles have a small size (less than 100 nm) with a narrow distribution, which could allow the PEC micelles to penetrate loosened endothelial junctions of a solid tumor. Previous results showed that the PEC micelle-based ODN delivery system could enhance the cellular uptake of ODN, efficiently protect from the nonspecific adhesion of the serum components and inhibit tumor growth [17, 21] . In addition, the flexible PEG shells surrounding the PEC core formed from electrostatic interaction between ODN and PEI are expected to protect the PEC micelles from the non-specific interaction with serum components, which results in the prolonged circulation of the micelles in blood stream. However, the PEG shells would also act as a steric barrier for the contact of the PEC micelles to the target cells, which might affect the efficiency of intracellular ODN delivery. The potential problem of the poor cellular contact of the PEC micelles could be overcome by conjugating a specific ligand at the end of PEG chain.
The synthesis of ODN-PEG-FA conjugate is shown in Fig. 1A . A heterofunctional PEG containing α-NHS-ester and ω-maleimide (MAL) was used. An NHS-ester group was first reacted with a 5 -primary amine group of ODN to form an ODN-PEG-MAL intermediate. Folic acid was functionalized by the thiol ( SH) group at its γ -carboxyl position. Folic acid contains two carboxyl groups (α and γ ). The γ -carboxyl group is known to have higher reactivity than the other α-carboxyl group and have minimal effect on receptor binding properties [22] . The SH-functionalized folic acid was then conjugated with the MAL group of ODN-PEG-MAL by a Michael-type addition. The conjugation was monitored by reversephase chromatography equipped with UV detectors at 260 nm. The conjugation yields of the ODN-PEG-MAL and ODN-PEG-FA were 61% and 85%, respectively. PEC micelles were formed in an aqueous solution by interacting ODN-PEG-FA conjugate with PEI (Fig. 1B) . PEI was selected, since PEI is one of the most commonly used polymeric gene carriers due to its high buffering capacity. Since not all of the amines in PEI are protonated at neutral pH, the stoichiometric molar ratio of the phosphate group in ODN and the amine group in PEI (N/P ratio) was adjusted at 2.5 : 1. At this N/P ratio, the surface charge of the polyelectrolyte complex between ODN and PEI became almost neutral, as determined by dynamic light scattering (DLS). The PEC micelles had an effective diameter of 92.3 nm with a relatively narrow size distribution (Fig. 2) .
To evaluate the cellular uptake of ODN-PEG-FA/PEI PEC micelles, 3 -FITClabeled ODN was used for the conjugation. KB cells, which over-express a FA receptor on their membrane surface, were treated with naked ODN, ODN-PEG/PEI PEC micelles and ODN-PEG-FA/PEI PEC micelles, and their cellular uptakes were comparatively determined by flow cytometric analysis. In an arbitrarily selected gate region (10 3 < FL1-H < 10 4 ), the cellular uptake efficiency of the ODN-PEG-FA/PEI PEC micelles against the KB cells was 71.4%. On the other hand, that of the ODN-PEG/PEI PEC micelles was 1.6% within the same gated region (Fig. 3) . The increased cellular uptake of the ODN-PEG-FA/PEI PEC micelles compared to that of the ODN-PEG/PEI PEC micelles could be attributed to the specific ligand-receptor interaction between the PEC micelles and the cell membrane, which led to the enhanced intracellular transport of the FA-modified PEC micelles by receptor-mediated endocytosis. This result agrees well with the previous report, in which PEC micelles formed from the electrostatic interaction between transferrinconjugated PEG-PEI and ODN demonstrated the enhanced cellular uptake of ODN [23] . The result also suggested that the FA moieties exposed on the surface of the PEC micelles could substantially promote the intracellular uptake of the micelles in FA receptor over-expressing cells, such as tumors. Improved tumor accumulation of FA-drug conjugate was also found in previous studies [24] .
Animal experiments were carried out to observe in vivo tumor deposition and biodistribution profiles of ODN in blood and other tissues (Fig. 4) . The formulations of naked ODN, ODN-PEG/PEI PEC micelles and ODN-PEG-FA/PEI PEC micelles, which contained a fluorescently labeled ODN, were intravenously administered through a tail vein. As expected, the naked ODN showed the fastest clearance from the blood. Both PEC micellar formulations (ODN-PEG/PEI and ODN-PEG-FA/PEI) maintained about 10-fold higher concentrations in the blood compared to naked ODN after 3 h. The prolonged circulation time of the PEC micelles could be attributed to the steric protection of PEG segment from non-specific adsorption of opsonins and other serum proteins. The PEC micelles composed of ODN-PEG conjugate and L-PEI demonstrated improved nuclease resistance and reduced serum protein adsorption [21] . Among other organs including liver, spleen, kidney and lung, the highest amount of ODN was detected in the liver. The tissue distribution of the PEC micelles showed very similar profiles to the previous results, in which poly(L-lysine)-b-PEG was used to generate PEC micelles by the electrostatic interaction with plasmid DNA [25] . The ODN-PEG-FA/PEI PEC formulation showed about 7-fold higher accumulation of ODN in the solid tumor after 24 h compared to that of the naked ODN alone. This was due to the prolonged circulation of the PEC micelles in the blood stream. More importantly, the increased ODN accumulation in the tumor was caused by the enhanced permeation and retention (EPR) effect [26] . The vascular endothelial junctions of fast-growing tumors are thought not to be as tight as normal vascular junctions [27] . The PEC micelles, having a size of less than 100 nm, could be passively targeted to the tumor tissue by passing through the loosened vascular endothelial junctions. In addition, FA receptor-mediated endocytosis would play an additional role in facilitating cellular uptake of the ODN-PEG-FA/PEI PEC micelles at the passively targeted site. Owing to the combined effect of the passive targeting and the improved cellular uptake, the ODN-PEG-FA/PEI PEC micelles demonstrated about 2-fold higher amount of ODN accumulation in the solid tumor compared to the ODN-PEG/PEI PEC micelles. The increased accumulation of the ODN-PEG-FA/PEI PEC micelles in the tumor region was only witnessed in the KB cell-implanted mice (Fig. 5) . No significant difference of ODN accumulation in the tumor was observed between ODN-PEG/PEI and ODN-PEG-FA/PEI PEC micelles in the FA-receptor-deficient A549 tumor xenograft model. This revealed that FA could be used as an efficient ligand for in vivo tumor targeting for the PEC micellar delivery system with a minimal loss of the useful properties of the ODN-PEG/PEI PEC micelles.
In conclusion, we introduced FA as a tumor-targeting moiety to the ODN/PEG PEC micelles. When systemically administered, the ODN-PEG-FA/PEI PEC micelles showed greater extent of ODN accumulation in the solid tumor overexpressing FA receptors than ODN or ODN-PEG/PEI PEC micelles. The ODN-PEG-FA/PEI PEC micelle system could be one of the promising antisense ODN delivery systems for cancer gene therapy.
